IQ-AI Limited

Equities

IQAI

JE00BD4H0R42

Healthcare Facilities & Services

Market Closed - London S.E. 11:35:12 2024-04-19 am EDT 5-day change 1st Jan Change
1.5 GBX 0.00% Intraday chart for IQ-AI Limited 0.00% -68.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
IQ-AI's Broker Exercises Option to Buy Shares in Placing MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development MT
IQ-AI shares sink on discounted placing fundraise AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback MT
IQ-AI subsidiary asked by FDA to resubmit and modify application AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program MT
IQ-AI celebrates USD100,000 grant for subsidiary AN
IQ-AI falls after subsidiary notes launch of treatment access scheme AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment MT
IQ-AI Subsidiary’s Glioblastoma Therapy Obtains Fast-Track Designation From US FDA MT
IQ-AI firm gets US FDA fast-track status for oral gallium maltolate AN
IQ-AI's Imaging Biometrics Discloses Positive Results in Early-stage Study of Potential Brain Cancer Treatment MT
IQ-AI stock rises on positive interim results from glioblastoma trial AN
IQ-AI Unit Seeks Pediatric Rare Disease Designation for Brain Tumor Treatment MT
IQ-AI says Imaging Biometrics submits paediatric rare disease request AN
IQ-AI Applies for FDA Pediatric Rare Disease Designation CI
IQ-AI subsidiary "central" to "landmark" brain cancer study AN
IQ-AI subsidiary wins orphan drug designation from US FDA AN
IQ-AI's Atypical Teratoid Rhabdoid Tumor Treatment Gains US FDA Orphan Drug Designation MT
IQ-AI Halts Trading on OTCQB Venture Market in US; London Shares Up 13% MT
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners MT
IQ-AI notes vindication of subsidiary's reduced gadolinium approach AN
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes MT
IQ-AI Shares Up 18% as Unit Strikes Commercial Deal with GE HealthCare MT
IQ-AI shares jump on subsidiary's GE Healthcare deal AN
Chart IQ-AI Limited
More charts
IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.
More about the company
  1. Stock Market
  2. Equities
  3. IQAI Stock
  4. News IQ-AI Limited
  5. IQ AI : Shares to Start Trading on OTCQB Venture Market in US